UCL Institute of Neurology



Genetic modifier for Huntington’s disease progression identified

A team led by UCL and Cardiff University researchers has developed a novel measure of disease progression for Huntington’s disease, which enabled them to identify a genetic modifier associated with how rapidly the disease progresses.

Publication date:

New Chief Operating Officer takes the helm at UK DRI

Bringing a wealth of experience and innovation in neurodegenerative diseases research, Dr Ivinson is currently Executive Director of the Institute for the Neurosciences, and of the Ann Romney Center for Neurologic Diseases, both at Brigham and Women’s Hospital, a Harvard Medical School affiliate.

Publication date: